Pyxis Oncology, Inc. (PYXS) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts PYXS Hot Sheet
Join SI Premium – FREE
Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q3 EPS of ($0.35), $0.03 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Sigma Lithium resumes full operations after signing TAC agreement
- Jefferies sees metals breakout on currency concerns
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
